JP2019501194A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019501194A5 JP2019501194A5 JP2018535324A JP2018535324A JP2019501194A5 JP 2019501194 A5 JP2019501194 A5 JP 2019501194A5 JP 2018535324 A JP2018535324 A JP 2018535324A JP 2018535324 A JP2018535324 A JP 2018535324A JP 2019501194 A5 JP2019501194 A5 JP 2019501194A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- opioid
- antagonist
- opioid antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662276691P | 2016-01-08 | 2016-01-08 | |
| US62/276,691 | 2016-01-08 | ||
| PCT/US2017/012452 WO2017120417A1 (en) | 2016-01-08 | 2017-01-06 | Treatments and prevention of opioid neonatal abstinence syndrome |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019501194A JP2019501194A (ja) | 2019-01-17 |
| JP2019501194A5 true JP2019501194A5 (OSRAM) | 2020-01-23 |
| JP7061568B2 JP7061568B2 (ja) | 2022-04-28 |
Family
ID=59274434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018535324A Active JP7061568B2 (ja) | 2016-01-08 | 2017-01-06 | オピオイド新生児薬物離脱症候群の処置及び予防 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US10925870B2 (OSRAM) |
| EP (1) | EP3400066B1 (OSRAM) |
| JP (1) | JP7061568B2 (OSRAM) |
| CN (1) | CN108778423A (OSRAM) |
| AU (1) | AU2017206041B2 (OSRAM) |
| CA (1) | CA3010609A1 (OSRAM) |
| DK (1) | DK3400066T3 (OSRAM) |
| WO (1) | WO2017120417A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL277801B2 (en) * | 2018-04-09 | 2025-06-01 | Katana Pharmaceuticals Inc | Oxytocin compositions and methods of use |
| US20220047580A1 (en) * | 2019-01-04 | 2022-02-17 | Aether Therapeutics Inc. | Method for treating drug or alcohol dependency |
| US10653690B1 (en) * | 2019-07-09 | 2020-05-19 | Orexo Ab | Pharmaceutical composition for nasal delivery |
| EP4366736A4 (en) * | 2021-07-06 | 2025-05-14 | Aether Therapeutics Inc. | LOW-DOSE NALTREXOL AND USES THEREOF |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001068080A2 (en) * | 2000-03-15 | 2001-09-20 | Wolfgang Sadee | Neutral antagonists and use thereof in treating drug abuse |
| JP2007500134A (ja) * | 2003-07-25 | 2007-01-11 | ユーロ−セルティーク エス．エイ． | 依存性退薬症状の治療 |
| CA2587406A1 (en) * | 2004-11-16 | 2006-05-26 | Limerick Neurosciences, Inc. | Methods and compositions for treating pain |
| JP2011500686A (ja) | 2007-10-18 | 2011-01-06 | アイコ バイオテクノロジー | オピオイドと中性アンタゴニストを用いる組合せ鎮痛剤 |
| US8748448B2 (en) | 2007-10-18 | 2014-06-10 | Aiko Biotechnology | Combination analgesic employing opioid agonist and neutral antagonist |
| WO2009079489A1 (en) * | 2007-12-17 | 2009-06-25 | The Ohio State University Research Foundation | Methods for screening of opioid receptor neutral antagonists and inverse agonists and uses thereof |
| CN102307895A (zh) * | 2008-12-04 | 2012-01-04 | 里兰斯坦福初级大学理事会 | 用于治疗或预防麻醉药停药症状的方法和组合物 |
-
2017
- 2017-01-06 DK DK17736392.6T patent/DK3400066T3/da active
- 2017-01-06 US US16/068,593 patent/US10925870B2/en active Active
- 2017-01-06 AU AU2017206041A patent/AU2017206041B2/en active Active
- 2017-01-06 EP EP17736392.6A patent/EP3400066B1/en active Active
- 2017-01-06 JP JP2018535324A patent/JP7061568B2/ja active Active
- 2017-01-06 CA CA3010609A patent/CA3010609A1/en active Pending
- 2017-01-06 CN CN201780015234.5A patent/CN108778423A/zh active Pending
- 2017-01-06 WO PCT/US2017/012452 patent/WO2017120417A1/en not_active Ceased
-
2021
- 2021-02-22 US US17/180,945 patent/US12161641B2/en active Active
-
2024
- 2024-12-06 US US18/972,105 patent/US20250177379A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019501194A5 (OSRAM) | ||
| JP2009525343A5 (OSRAM) | ||
| JP2017510607A5 (OSRAM) | ||
| Sturn et al. | Low-dose naltrexone: a new therapy option for complex regional pain syndrome type I patients | |
| JP2016505050A5 (OSRAM) | ||
| JP2016520114A5 (OSRAM) | ||
| CR20240015A (es) | COMPOSICIÓN FARMACÉUTICA CON ANTAGONISTA DEL RECEPTOR DE MINERALOCORTICOIDES Y SU USO (Divisional Expediente 2019-203) | |
| Patel et al. | Opioids for pain after oral surgery | |
| EP2830605A1 (en) | A combination medicament comprising phenylephrine and paracetamol | |
| KR101978459B1 (ko) | 조루증 치료용 약학 조성물 및 조루증 치료 방법 | |
| JP6940265B2 (ja) | 止瀉剤組成物 | |
| Linn et al. | Peripherally restricted μ-opioid receptor antagonists: a review | |
| JP6940264B2 (ja) | 止瀉剤組成物 | |
| Yeomanson et al. | Paediatric palliative care: intravenous methylnaltrexone relieves constipation | |
| KR101598283B1 (ko) | 안전성 및 효능이 증가된 월경통 완화 또는 치료용 복합제 조성물 | |
| NZ744112B2 (en) | Treatments and prevention of opioid neonatal abstinence syndrome | |
| CN109966291A (zh) | 化合物sb216763在制备预防和/或治疗脑血管疾病的药物中的应用及其药物组合物 | |
| NZ744112A (en) | Treatments and prevention of opioid neonatal abstinence syndrome | |
| CN103316346B (zh) | 治疗癫痫的药物组合物 | |
| JP6753661B2 (ja) | 止瀉剤組成物 | |
| Hellwig et al. | The Role of Methylnaltrexone in Opioid-induced Constipation. | |
| JP6676326B2 (ja) | 止瀉用の漢方製剤 | |
| Chiou et al. | The use of transdermal fentanyl in cancer pain—a compliance study of outpatients in Taiwan | |
| Jerome Check et al. | COMPLETE RESOLUTION OF THE BURNING MOUTH SYNDROME IN A NORMAL ESTROGENIC WOMAN FOLLOWING TREATMENT WITH AMPHETAMINES | |
| Maetani | Chlorpromazine/promethazine/phenobarbital/levomepromazine |